Randomized phase 3 study of lenalidomide versus chlorambucil as first-line therapy for older patients with chronic lymphocytic leukemia (the ORIGIN trial)

被引：22

作者：

Chanan-Khan, A. ^{[1
]}

Egyed, M. ^{[2
]}

Robak, T. ^{[3
]}

Martinelli de Oliveira, F. A. ^{[4
]}

Echeveste, M. A. ^{[5
]}

Dolan, S. ^{[6
]}

Desjardins, P. ^{[7
]}

Blonski, J. Z. ^{[3
]}

Mei, J. ^{[8
]}

Golany, N. ^{[8
]}

Zhang, J. ^{[8
]}

Gribben, J. G. ^{[9
]}

机构：

[1] Mayo Clin, Div Hematol & Oncol, Jacksonville, FL 32224 USA

[2] Kaposi Mor Oktato Korhaz, Dept Internal Med, Kaposvar, Hungary

[3] Med Univ Lodz, Dept Hematol, Lodz, Poland

[4] Hosp Erasto Gaertner, Dept Oncol, Curitiba, Parana, Brazil

[5] Hosp Univ Donostia, Hematol Serv, San Sebastian, Spain

[6] St Johns Hosp, Div Hematol, St John, NB, Canada

[7] Hosp Charles LeMoyne, Dept Hematol, Greenfield Pk, PQ, Canada

[8] Celgene Corp, Summit, NJ USA

[9] Barts Canc Inst, Ctr Haemato Oncol, London, England

来源：

LEUKEMIA | 2017年 / 31卷 / 05期

关键词：

D O I：

10.1038/leu.2017.47

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：1240 / 1243

页数：5

共 50 条

[21] Fludarabine plus cyclophosphamide versus fludarabine alone in first-line therapy of younger patients with chronic lymphocytic leukemia
Eichhorst, BF
Busch, R
Hopfinger, G
Pasold, R
Hensel, M
Steinbrecher, C
Siehl, S
Jäger, U
Bergmann, M
Stilgenbauer, S
Schweighofer, C
Wendtner, CM
Döhner, H
Brittinger, G
Emmerich, B
Hallek, M
BLOOD, 2006, 107 (03) : 885 - 891
[22] Postremissional rituximab administration for the treatment of older chronic lymphocytic leukemia (CLL) patients responsive to first line therapy with chlorambucil and prednisone.
Mauro, FR
Gentile, M
De Propris, MS
Giammartini, E
Buffolino, S
Ghia, M
Paoloni, F
Valle, V
Guarini, AR
Alimena, G
Mandelli, F
Foa, R
BLOOD, 2003, 102 (11) : 674A - 674A
[23] Impact of prognostic factors on outcome in a phase III study comparing alemtuzumab to chlorambucil as first-line therapy for B-cell chronic lymphocytic leukemia (BCLL)
Mayer, J.
Robak, T.
Skotnicki, A.
Jaksic, B.
Dmoszynska, A.
Sirard, C.
Hillmen, P.
JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
[24] Debate: What Is Optimal First-Line Therapy for Chronic Lymphocytic Leukemia?
Shadman, Mazyar
Stephens, Deborah M.
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2020, 18 (07): : 993 - 997
[25] First-line therapy of chronic lymphocytic leukemia in the elderly: be careful with overtreatment
Bauduer, Frederic
PRESSE MEDICALE, 2009, 38 (01): : 140 - 142
[26] Optimal First-Line Therapy for Previously Untreated Chronic Lymphocytic Leukemia
Brown, Jennifer R.
ONCOLOGY-NEW YORK, 2015, 29 (06): : 442 - +
[27] OBINUTUZUMAB IN COMBINATION WITH CHLORAMBUCIL IN THE FIRST LINE OF TREATMENT OF ELDERLY PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA
Markova, E. E.
Nikitin, E. A.
Dmitrieva, E. A.
Mayorova, S. Yu
Kochkareva, Yu B.
Naumova, E., V
Lugovskaya, S. A.
Pochtar, M. E.
Petrenko, A. A.
Kislova, M., I
Biderman, B., V
Sudarikov, A. B.
Obukhova, T. N.
Ptushkin, V. V.
GEMATOLOGIYA I TRANSFUZIOLOGIYA, 2022, 67 (04): : 478 - 490
[28] A randomized phase 2 trial of azacitidine with or without durvalumab as first-line therapy for older patients with AML
Zeidan, Amer M.
Boss, Isaac
Beach, C. L.
Copeland, Wilbert B.
Thompson, Ethan
Fox, Brian A.
Hasle, Vanessa E.
Hellmann, Andrzej
Taussig, David C.
Tormo, Mar
Voso, Maria Teresa
Cavenagh, James
O'Connor, Tim
Previtali, Alessandro
Rose, Shelonitda
Silverman, Lewis R.
BLOOD ADVANCES, 2022, 6 (07) : 2219 - 2229
[29] First line therapy of patients (pts) with advanced chronic lymphocytic leukemia (CLL) older than 65 years with fludarabine versus chlorambucil: Interim analysis of a phase III study of the German CLL Study Group (GCLLSG).
Schmitt, BF
Kneba, M
Ritgen, M
Stauch, M
Emmerich, B
Bergmann, M
Busch, R
Wendtner, CM
Hallek, M
BLOOD, 2002, 100 (11) : 387A - 387A
[30] Phase III Randomized Study of Bendamustine Compared With Chlorambucil in Previously Untreated Patients With Chronic Lymphocytic Leukemia
Knauf, Wolfgang U.
Lissichkov, Toshko
Aldaoud, Ali
Liberati, Anna
Loscertales, Javier
Herbrecht, Raoul
Juliusson, Gunnar
Postner, Gerhard
Gercheva, Liana
Goranov, Stefan
Becker, Martin
Fricke, Hans-Joerg
Huguet, Francoise
Del Giudice, Ilaria
Klein, Peter
Tremmel, Lothar
Merkle, Karlheinz
Montillo, Marco
JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (26) : 4378 - 4384

← 1 2 3 4 5 →